 Ioan Lina
Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laryngostenosis | 23 | 2026 | 54 | 6.850 |
Why?
| | Tracheal Stenosis | 10 | 2024 | 39 | 3.160 |
Why?
| | Cicatrix | 4 | 2024 | 69 | 1.020 |
Why?
| | Lumbar Vertebrae | 3 | 2021 | 252 | 1.000 |
Why?
| | Voice Quality | 1 | 2026 | 23 | 0.950 |
Why?
| | Tracheostomy | 7 | 2025 | 142 | 0.870 |
Why?
| | Constriction, Pathologic | 8 | 2023 | 248 | 0.820 |
Why?
| | Spinal Fusion | 3 | 2018 | 260 | 0.800 |
Why?
| | Machine Learning | 2 | 2026 | 585 | 0.760 |
Why?
| | Myofibroblasts | 1 | 2020 | 143 | 0.580 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2018 | 59 | 0.550 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4557 | 0.490 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 2583 | 0.480 |
Why?
| | Iatrogenic Disease | 6 | 2021 | 76 | 0.470 |
Why?
| | Trachea | 6 | 2024 | 261 | 0.440 |
Why?
| | Laryngoscopy | 2 | 2025 | 117 | 0.410 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2014 | 77 | 0.400 |
Why?
| | Parathyroid Hormone | 1 | 2014 | 112 | 0.390 |
Why?
| | Perceptual Masking | 1 | 2013 | 16 | 0.380 |
Why?
| | Cadherins | 2 | 2025 | 201 | 0.370 |
Why?
| | Brain Stem | 1 | 2013 | 95 | 0.370 |
Why?
| | Noise | 1 | 2013 | 71 | 0.360 |
Why?
| | Auditory Perception | 1 | 2013 | 114 | 0.350 |
Why?
| | Transforming Growth Factor beta | 1 | 2014 | 479 | 0.340 |
Why?
| | Drug-Eluting Stents | 2 | 2023 | 88 | 0.340 |
Why?
| | Cricoid Cartilage | 3 | 2026 | 15 | 0.320 |
Why?
| | Case-Control Studies | 5 | 2026 | 3604 | 0.320 |
Why?
| | Intubation, Intratracheal | 3 | 2022 | 320 | 0.310 |
Why?
| | Fibroblasts | 4 | 2021 | 1034 | 0.280 |
Why?
| | Clinical Trials as Topic | 2 | 2025 | 1053 | 0.280 |
Why?
| | Calgranulin B | 2 | 2024 | 10 | 0.270 |
Why?
| | Calgranulin A | 2 | 2024 | 11 | 0.270 |
Why?
| | Arytenoid Cartilage | 1 | 2026 | 6 | 0.240 |
Why?
| | Acromegaly | 1 | 2026 | 16 | 0.240 |
Why?
| | Primary Cell Culture | 3 | 2020 | 173 | 0.230 |
Why?
| | Macrophages | 3 | 2023 | 1511 | 0.230 |
Why?
| | Joint Diseases | 1 | 2026 | 62 | 0.220 |
Why?
| | Humans | 34 | 2026 | 144759 | 0.220 |
Why?
| | Fibrosis | 6 | 2025 | 548 | 0.220 |
Why?
| | Infectious Disease Transmission, Patient-to-Professional | 2 | 2022 | 20 | 0.220 |
Why?
| | Dilatation | 2 | 2024 | 72 | 0.220 |
Why?
| | Cohort Studies | 4 | 2024 | 5960 | 0.210 |
Why?
| | Everolimus | 1 | 2024 | 111 | 0.210 |
Why?
| | Airway Obstruction | 1 | 2026 | 162 | 0.200 |
Why?
| | Treatment Outcome | 7 | 2025 | 11679 | 0.200 |
Why?
| | Neurosurgical Procedures | 2 | 2015 | 202 | 0.200 |
Why?
| | Spine | 2 | 2015 | 182 | 0.190 |
Why?
| | Laryngoscopes | 1 | 2023 | 45 | 0.190 |
Why?
| | Botulinum Toxins | 1 | 2023 | 46 | 0.190 |
Why?
| | Flow Cytometry | 2 | 2024 | 1173 | 0.190 |
Why?
| | Biopsy | 3 | 2020 | 1075 | 0.190 |
Why?
| | Keratin-14 | 1 | 2022 | 15 | 0.180 |
Why?
| | Cell Proliferation | 2 | 2020 | 2496 | 0.180 |
Why?
| | Middle Aged | 12 | 2026 | 35875 | 0.180 |
Why?
| | Mucin 5AC | 1 | 2022 | 70 | 0.170 |
Why?
| | Fractures, Compression | 1 | 2021 | 15 | 0.170 |
Why?
| | Diazooxonorleucine | 1 | 2021 | 2 | 0.170 |
Why?
| | Medical Staff, Hospital | 1 | 2021 | 80 | 0.170 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2021 | 46 | 0.170 |
Why?
| | Phenformin | 1 | 2020 | 1 | 0.170 |
Why?
| | Virion | 1 | 2021 | 111 | 0.160 |
Why?
| | Amobarbital | 1 | 2020 | 2 | 0.160 |
Why?
| | Delayed Diagnosis | 1 | 2021 | 95 | 0.160 |
Why?
| | Tubulin | 1 | 2022 | 147 | 0.160 |
Why?
| | Glottis | 1 | 2020 | 20 | 0.160 |
Why?
| | Spinal Fractures | 1 | 2021 | 73 | 0.160 |
Why?
| | Aerosols | 1 | 2021 | 186 | 0.160 |
Why?
| | Adult | 12 | 2026 | 40449 | 0.160 |
Why?
| | Glutamine | 1 | 2021 | 109 | 0.160 |
Why?
| | Spinal Neoplasms | 2 | 2021 | 37 | 0.160 |
Why?
| | Immunosuppressive Agents | 2 | 2024 | 846 | 0.160 |
Why?
| | Glutaminase | 1 | 2020 | 11 | 0.160 |
Why?
| | Male | 16 | 2026 | 72315 | 0.160 |
Why?
| | Ketoglutaric Acids | 1 | 2020 | 23 | 0.160 |
Why?
| | Female | 16 | 2026 | 78271 | 0.160 |
Why?
| | Infection Control | 1 | 2021 | 172 | 0.150 |
Why?
| | Thiadiazoles | 1 | 2020 | 27 | 0.150 |
Why?
| | Oxidative Phosphorylation | 1 | 2020 | 210 | 0.150 |
Why?
| | Animals | 11 | 2025 | 38058 | 0.150 |
Why?
| | Sulfides | 1 | 2020 | 91 | 0.150 |
Why?
| | Research Design | 1 | 2025 | 1135 | 0.140 |
Why?
| | X-Ray Microtomography | 1 | 2018 | 107 | 0.140 |
Why?
| | Luminescent Measurements | 1 | 2018 | 76 | 0.140 |
Why?
| | Aged | 6 | 2026 | 25913 | 0.140 |
Why?
| | Glycolysis | 1 | 2020 | 339 | 0.140 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2020 | 264 | 0.140 |
Why?
| | B7-H1 Antigen | 1 | 2020 | 241 | 0.130 |
Why?
| | Severity of Illness Index | 1 | 2026 | 2925 | 0.130 |
Why?
| | Rabbits | 2 | 2021 | 648 | 0.130 |
Why?
| | Mucous Membrane | 3 | 2024 | 127 | 0.130 |
Why?
| | Muscle Contraction | 1 | 2020 | 429 | 0.130 |
Why?
| | Bone Marrow Transplantation | 1 | 2018 | 294 | 0.130 |
Why?
| | Radiosurgery | 1 | 2021 | 400 | 0.130 |
Why?
| | Metformin | 1 | 2020 | 318 | 0.120 |
Why?
| | Tissue Scaffolds | 1 | 2018 | 223 | 0.120 |
Why?
| | Biomechanical Phenomena | 2 | 2021 | 842 | 0.120 |
Why?
| | Clinical Competence | 1 | 2024 | 1244 | 0.120 |
Why?
| | Cells, Cultured | 2 | 2020 | 4154 | 0.120 |
Why?
| | Diffusion Chambers, Culture | 1 | 2015 | 9 | 0.120 |
Why?
| | Hospitals, General | 1 | 2015 | 26 | 0.120 |
Why?
| | Cell Survival | 1 | 2018 | 1098 | 0.110 |
Why?
| | Thoracic Vertebrae | 1 | 2016 | 79 | 0.110 |
Why?
| | Prospective Studies | 3 | 2024 | 7990 | 0.110 |
Why?
| | Failed Back Surgery Syndrome | 1 | 2015 | 1 | 0.110 |
Why?
| | Internal Fixators | 1 | 2015 | 32 | 0.110 |
Why?
| | Bone Cements | 1 | 2015 | 39 | 0.110 |
Why?
| | Pedicle Screws | 1 | 2015 | 21 | 0.110 |
Why?
| | Energy Metabolism | 1 | 2020 | 935 | 0.100 |
Why?
| | Analgesia | 1 | 2015 | 105 | 0.100 |
Why?
| | Craniotomy | 1 | 2014 | 82 | 0.100 |
Why?
| | Cervical Vertebrae | 1 | 2015 | 158 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 920 | 0.100 |
Why?
| | RNA, Messenger | 1 | 2022 | 2832 | 0.100 |
Why?
| | Otolaryngology | 1 | 2015 | 108 | 0.100 |
Why?
| | Bone Transplantation | 1 | 2014 | 86 | 0.100 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2182 | 0.100 |
Why?
| | Manikins | 2 | 2024 | 35 | 0.100 |
Why?
| | Spinal Cord Compression | 1 | 2013 | 22 | 0.100 |
Why?
| | Mice, Inbred CBA | 1 | 2013 | 57 | 0.100 |
Why?
| | Ribs | 1 | 2013 | 35 | 0.100 |
Why?
| | Pitch Perception | 1 | 2013 | 14 | 0.100 |
Why?
| | Orthopedic Procedures | 1 | 2016 | 243 | 0.100 |
Why?
| | Audiometry, Pure-Tone | 1 | 2013 | 33 | 0.100 |
Why?
| | Aneurysm | 1 | 2013 | 37 | 0.100 |
Why?
| | Surgical Flaps | 1 | 2014 | 142 | 0.100 |
Why?
| | Analgesics | 1 | 2015 | 228 | 0.100 |
Why?
| | Transplantation, Autologous | 1 | 2014 | 290 | 0.090 |
Why?
| | Neurofibromatosis 1 | 1 | 2013 | 54 | 0.090 |
Why?
| | Auditory Threshold | 1 | 2013 | 51 | 0.090 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 2013 | 50 | 0.090 |
Why?
| | Recurrence | 2 | 2025 | 1135 | 0.090 |
Why?
| | Acoustic Stimulation | 1 | 2013 | 333 | 0.090 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 1047 | 0.080 |
Why?
| | Combined Modality Therapy | 1 | 2014 | 1266 | 0.080 |
Why?
| | Mice | 5 | 2025 | 18339 | 0.080 |
Why?
| | Hypoglycemic Agents | 1 | 2020 | 1387 | 0.080 |
Why?
| | Recombinant Proteins | 1 | 2014 | 1370 | 0.080 |
Why?
| | Electroencephalography | 1 | 2013 | 532 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2027 | 0.080 |
Why?
| | Swine | 2 | 2022 | 833 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 6048 | 0.070 |
Why?
| | Collagen | 2 | 2021 | 456 | 0.070 |
Why?
| | Gene Expression | 2 | 2024 | 1490 | 0.070 |
Why?
| | Endoscopy | 2 | 2023 | 316 | 0.060 |
Why?
| | Pilot Projects | 2 | 2024 | 1886 | 0.060 |
Why?
| | Time Factors | 2 | 2021 | 7173 | 0.060 |
Why?
| | Retrospective Studies | 5 | 2025 | 17066 | 0.060 |
Why?
| | Young Adult | 2 | 2020 | 14105 | 0.060 |
Why?
| | Fiber Optic Technology | 1 | 2024 | 24 | 0.050 |
Why?
| | Brain Neoplasms | 1 | 2014 | 1318 | 0.050 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5408 | 0.050 |
Why?
| | North America | 1 | 2025 | 310 | 0.050 |
Why?
| | Esophageal Sphincter, Upper | 1 | 2023 | 8 | 0.050 |
Why?
| | Permeability | 1 | 2023 | 168 | 0.050 |
Why?
| | Biomarkers | 2 | 2024 | 4271 | 0.050 |
Why?
| | Consensus | 1 | 2025 | 488 | 0.050 |
Why?
| | Blotting, Western | 1 | 2025 | 1187 | 0.050 |
Why?
| | Epithelium | 1 | 2023 | 314 | 0.050 |
Why?
| | Th17 Cells | 1 | 2023 | 101 | 0.050 |
Why?
| | Administration, Oral | 1 | 2024 | 847 | 0.040 |
Why?
| | Sirolimus | 1 | 2023 | 281 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2026 | 1489 | 0.040 |
Why?
| | Electrocoagulation | 1 | 2021 | 36 | 0.040 |
Why?
| | Humidity | 1 | 2021 | 52 | 0.040 |
Why?
| | Sheep | 1 | 2024 | 880 | 0.040 |
Why?
| | Injections, Intraperitoneal | 1 | 2021 | 116 | 0.040 |
Why?
| | Masks | 1 | 2021 | 70 | 0.040 |
Why?
| | Evaluation Studies as Topic | 1 | 2020 | 166 | 0.040 |
Why?
| | Equipment Design | 1 | 2022 | 530 | 0.040 |
Why?
| | CD11b Antigen | 1 | 2020 | 60 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2021 | 170 | 0.040 |
Why?
| | Larynx | 1 | 2020 | 56 | 0.040 |
Why?
| | Cellular Microenvironment | 1 | 2020 | 94 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2020 | 370 | 0.040 |
Why?
| | Monocytes | 1 | 2023 | 538 | 0.040 |
Why?
| | Stents | 1 | 2024 | 556 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2023 | 449 | 0.040 |
Why?
| | Receptors, Immunologic | 1 | 2020 | 206 | 0.040 |
Why?
| | Bleomycin | 1 | 2021 | 253 | 0.040 |
Why?
| | Software | 1 | 2024 | 690 | 0.040 |
Why?
| | Hot Temperature | 1 | 2021 | 407 | 0.030 |
Why?
| | Cell Communication | 1 | 2020 | 324 | 0.030 |
Why?
| | Postoperative Complications | 2 | 2025 | 2919 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2020 | 1047 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 2020 | 496 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2025 | 3121 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2020 | 375 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2023 | 1125 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1716 | 0.030 |
Why?
| | Prognosis | 1 | 2024 | 4282 | 0.030 |
Why?
| | Hospital Departments | 1 | 2015 | 9 | 0.030 |
Why?
| | Neurotology | 1 | 2015 | 5 | 0.030 |
Why?
| | Biomedical Engineering | 1 | 2015 | 29 | 0.030 |
Why?
| | Maryland | 1 | 2015 | 66 | 0.030 |
Why?
| | Skull Base | 1 | 2015 | 54 | 0.030 |
Why?
| | Audiology | 1 | 2015 | 21 | 0.030 |
Why?
| | Calcium Phosphates | 1 | 2015 | 28 | 0.030 |
Why?
| | Polymethyl Methacrylate | 1 | 2015 | 21 | 0.030 |
Why?
| | Health Personnel | 1 | 2022 | 748 | 0.030 |
Why?
| | Decompression, Surgical | 1 | 2016 | 116 | 0.030 |
Why?
| | Surgery, Plastic | 1 | 2015 | 52 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2882 | 0.030 |
Why?
| | History, 21st Century | 1 | 2015 | 219 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3162 | 0.030 |
Why?
| | Bronchoscopy | 1 | 2015 | 227 | 0.030 |
Why?
| | History, 20th Century | 1 | 2015 | 325 | 0.030 |
Why?
| | Neurology | 1 | 2015 | 112 | 0.030 |
Why?
| | Vestibule, Labyrinth | 1 | 2015 | 91 | 0.030 |
Why?
| | Face | 1 | 2015 | 173 | 0.030 |
Why?
| | Hearing | 1 | 2015 | 132 | 0.030 |
Why?
| | Bone Screws | 1 | 2015 | 110 | 0.030 |
Why?
| | Forecasting | 1 | 2015 | 391 | 0.020 |
Why?
| | Spinal Cord Diseases | 1 | 2013 | 41 | 0.020 |
Why?
| | Interprofessional Relations | 1 | 2015 | 281 | 0.020 |
Why?
| | Back Pain | 1 | 2013 | 52 | 0.020 |
Why?
| | Pain Measurement | 1 | 2015 | 552 | 0.020 |
Why?
| | Osteoporosis | 1 | 2015 | 236 | 0.020 |
Why?
| | Research | 1 | 2015 | 431 | 0.020 |
Why?
| | Inflammation | 1 | 2023 | 2878 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 3185 | 0.020 |
Why?
| | Radiography | 1 | 2013 | 844 | 0.020 |
Why?
| | Embolization, Therapeutic | 1 | 2013 | 242 | 0.020 |
Why?
| | Head and Neck Neoplasms | 1 | 2015 | 558 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10779 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2947 | 0.020 |
Why?
| | Child | 2 | 2015 | 22633 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2014 | 8265 | 0.010 |
Why?
| | Adolescent | 1 | 2014 | 22428 | 0.010 |
Why?
|
|
Lina's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|